We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 2,068

Christian Louboutin’s fight against counterfeits of their lipsticks in China
  • King & Wood Mallesons
  • China
  • June 16 2017

The specific measures established in this case provide a guiding standard to determine essential factors of irreparable damage to a patented design


China: Understanding utility model patent and design patent protection
  • Tsai Lee & Chen Patent Attorneys & Attorneys at Law
  • China
  • February 18 2016

Utility models and designs are two available categories of patents in China. Utility models are sometimes referred to as small inventions because


Total Won the Invalidation Case against Versalis
  • Liu, Shen & Associates
  • China, USA
  • May 26 2017

On May 17, 2017, with respect to an Invalidation Request filed by Total Research & Technology Feluy against invention patent No. 200980116333.8 of


The calculation of damages awards in patent infringement cases in 15 jurisdictions
  • Lexology
  • China, Denmark, Ecuador, Finland, France, Greece, Pakistan, Romania, Turkey, United Kingdom, India, Israel, Italy, Japan, Malaysia, Netherlands
  • February 24 2017

A structured guide to the calculation of damages awards in patent infringement cases in China, Denmark, Ecuador, Finland, France, Greece, India, Israel, Italy, Japan, Malaysia, Netherlands, Pakistan, Romania, Turkey and the United Kingdom


Patent term extensions and regulatory exclusivities for pharmaceuticals in Asia and South America
  • Morrison & Foerster LLP
  • Argentina, Mexico, Philippines, South Korea, Thailand, USA, Vietnam, Brazil, Chile, China, Hong Kong, Japan, Malaysia
  • June 27 2012

Patent protection for pharmaceutical products has an impact on the pharmaceutical market and innovation


China may become more liberal towards business method and software related patents
  • Reinhold Cohn Group
  • China, USA
  • December 26 2016

On 27 October 2016, the State Intellectual Property Office of China (SIPO) published, for comments by the public, proposed draft revisions to its


The China Food and Drug Administration’s 2017 Reform Efforts Highlighted Seven Priorities
  • Sidley Austin LLP
  • China
  • March 1 2017

On February 27, in a press conference held by China's State Council, Mr. Bi Jingquan, the head of the China Food and Drug Administration (CFDA


10 Advantages of Chinese Utility Model Patents
  • Deacons
  • China
  • July 12 2016

Many countries have a system for the protection of minor inventions including Australia, Germany, Japan and Korea. In China, this has been


Chinese Food and Drug Administration (CFDA) Proposes New Patent Linkage and Data Protection Regime
  • Spruson & Ferguson
  • China
  • May 18 2017

On 12 May, 2017 the CFDA published its intention to work on a new patent linkage and data protection system for China as part of a reform of its


The criteria for patentability in 15 jurisdictions
  • Lexology
  • China, Denmark, Ecuador, Finland, France, Global, Netherlands, Pakistan, Romania, Turkey, United Kingdom, Greece, India, Israel, Italy, Japan, Malaysia
  • February 23 2017

A structured guide to the criteria for patentability in China, Denmark, Ecuador, Finland, France, Greece, India, Israel, Italy, Japan, Malaysia, Netherlands, Pakistan, Romania, Turkey and the United Kingdom